by Raleigh Malik | Feb 20, 2013
Industry professionals, academics and FDA all agree that the cost of drug development is unsustainable, according a recent article on the San Francisco Business Times. To tackle the problem, FDA is looking at ways to change the drug development process. At the...
by Raleigh Malik | Feb 20, 2013
As of January 28, 2013 the US Small Business Innovation Research (SBIR) program is operating under a new set of rules drafted into the National Defense Authorization Act for the FY 2012. The redesigned platform will bring in smaller biopharma businesses and other...
by Raleigh Malik | Feb 20, 2013
Last week, FDA released draft guidance entitled, “Alzheimer’s Disease: Developing Drugs for the Treatment of Early Stage Disease,” which addresses the FDA’s view regarding the selection of patients with early Alzheimer’s Disease (AD), or at risk patients for clinical...
by Raleigh Malik | Feb 20, 2013
The European Lead Factory, an international consortium of pharmaceutical companies, academia and research organizations has initiated a new platform to improve European drug discovery, per a recent article on pharmtech.com. In a five year time frame, the 30 partner...
by Raleigh Malik | Feb 19, 2013
The Midwest Discussion group (MWDG) of the ASQ Biomedical division invites you to tour the McKenzie Center for Innovation and Technology, a comprehensive high school. When: February 28, 2013 Time: 5:30-8:30 pm Where: McKenzie Center for Innovation and...
